We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Kindeva

News List

Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate contractpharma
April 08, 2021
Kindeva Drug Delivery L.P. and Cambridge Healthcare Innovations Limited (CHI) have entered into a collaboration to develop and commercialize CHI’s αeolus dry-powder inhaler (DPI) platform technology.
FDA Grants Tentative Approval to Generic Version of Symbicort contractpharma
March 10, 2021
Product is indicated for certain patients with asthma or chronic obstructive pulmonary disease (COPD).
Kindeva Launches as an Independent Company contractpharma
May 05, 2020
Kindeva Drug Delivery, formerly 3M Drug Delivery Systems, has launched as an independent company following its acquisition by Altaris Capital Partners in a transaction valued at $650 million.